Novel transcatheter prostheses for TAVI

Session comprising selected EuroPCR 2019 abstract submissions

Chairperson: J. Byrne
SHOW MORE

Summary

Consult this session to learn more about the clinical outcomes of novel transcatheter prostheses for TAVI, such as the 2nd generation Colibri, the self-expanding CENTERA, and more!

Presentations available when logged in:

  • Early feasibility trial of the second-generation Colibri dry, pre-mounted, pre-packaged TAVR valve with six-month outcome
  • Evaluation of the novel, self-expanding CENTERA transcatheter heart valve system at two years
  • TAVR using the Hydra self-expanding bioprosthesis- A single-centre experience